These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 3467372)

  • 1. Intracellular growth factors in polycythemia vera and other myeloproliferative disorders.
    Eid J; Ebert RF; Gesell MS; Spivak JL
    Proc Natl Acad Sci U S A; 1987 Jan; 84(2):532-6. PubMed ID: 3467372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.
    Moliterno AR; Hankins WD; Spivak JL
    N Engl J Med; 1998 Feb; 338(9):572-80. PubMed ID: 9475764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the mitogenic activity of platelet-derived growth factor(s) in patients with myeloproliferative disease.
    Caenazzo A; Pietrogrande F; Polato G; Piva E; Masiero M; Sgarabotto D; Girolami A
    Acta Haematol; 1989; 81(3):131-5. PubMed ID: 2496560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The myeloproliferative disorders. Correlation between clinical evolution and alterations of granulopoiesis.
    Greenberg P; Mara B; Bax I; Brossel R; Schrier S
    Am J Med; 1976 Dec; 61(6):878-91. PubMed ID: 1087534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Observations on the in vitro growth of peripheral leucocytes from patients with myeloproliferative disorders.
    Pegrum GD
    Br J Haematol; 1966 Nov; 12(6):689-96. PubMed ID: 5224278
    [No Abstract]   [Full Text] [Related]  

  • 6. Phagocytosis in myeloproliferative disorders.
    Corberand J; LaHarrague P; De Larrard B; Nguyen F; Pris J
    Am J Clin Pathol; 1980 Sep; 74(3):301-5. PubMed ID: 6932175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous erythroid colony formation by peripheral blood mononuclear cells from patients with myelofibrosis and polycythemia vera.
    Lutton JD; Levere RD
    Acta Haematol; 1979; 62(2):94-9. PubMed ID: 119408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet and fibrinogen kinetics in the chronic myeloproliferative disorders.
    Brodsky I; Kahn SB; Ross EM; Petkov G
    Cancer; 1972 Dec; 30(6):1444-50. PubMed ID: 4509103
    [No Abstract]   [Full Text] [Related]  

  • 9. [Megakaryocytopoiesis in myeloproliferative disorders].
    Podolak-Dawidziak M
    Acta Haematol Pol; 1992; 23(2 Suppl 1):19-22. PubMed ID: 1488868
    [No Abstract]   [Full Text] [Related]  

  • 10. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous erythroid colony formation in myeloproliferative diseases does not depend on T cells.
    Robak T; Hast R; Goldman JM
    Exp Hematol; 1986 Mar; 14(3):197-201. PubMed ID: 3485053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical studies in chronic myelocytic leukemia, polycythemia vera and other idiopathic myeloproliferative disorders.
    VALENTINE WN; BECK WS; FOLLETTE JH; MILLS H; LAWRENCE JS
    Blood; 1952 Oct; 7(10):959-77. PubMed ID: 12977828
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoiesis in culture.
    Eaves AC; Eaves CJ
    Clin Haematol; 1984 Jun; 13(2):371-91. PubMed ID: 6432390
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet defects in the myeloproliferative disorders.
    Inceman S; Tangün Y
    Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased fibroblast colony stimulating activity (F-CSA) in serum of myeloproliferative disorders.
    Han ZC; Briere J; Parent D; Abgrall JF; Sensebe L
    J Biol Regul Homeost Agents; 1988; 2(3):119-24. PubMed ID: 3267102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutropenia caused by hairy cell leukemia in a patient with myelofibrosis secondary to polycythemia vera: a case report.
    Habberstad AH; Tran HTT; Randen U; Spetalen S; Dybedal I; Tjønnfjord GE; Dahm AEA
    J Med Case Rep; 2018 Apr; 12(1):105. PubMed ID: 29685167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue culture of bone marrow. 3. Myelostimulatory factors in serum of patients with myeloproliferative diseases.
    Reisner EH
    Cancer; 1967 Oct; 20(10):1679-88. PubMed ID: 5234302
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood histamine in the differential diagnosis of myeloid splenomegaly (osteomyelofibrosis) and other myeloproliferative disorders.
    Gingold N
    Rev Roum Med; 1974; 12(1):15-8. PubMed ID: 4533361
    [No Abstract]   [Full Text] [Related]  

  • 19. Spontaneous platelet aggregation in myeloproliferative disorders. A preliminary study.
    Barbui T; Battista R; Dini E
    Acta Haematol; 1973; 50(1):25-9. PubMed ID: 4200801
    [No Abstract]   [Full Text] [Related]  

  • 20. Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction.
    Oppliger Leibundgut E; Brunold C; Marti D; Horn MP; Seiler C; Schroeder V; Schmid JP; Tobler A; Zwicky C
    Haematologica; 2005 Jul; 90(7):875-80. PubMed ID: 15996924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.